Propanc Biopharma, Inc. (PPCB) income statement
PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.88−0.01 (-0.53%)
Close on Nov 17, 2026Market cap $1.85MP/E –Yield –
Propanc Biopharma, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -161.9%
Financial strength
- Current ratio
- 2.47
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 8.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.26
- Dividend yield
- –
See a number that looks wrong?